Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY: TEVA )

17.75 -0.79 (-4.23%)
Streaming Delayed Price Updated: 12:44 PM EST, Jan 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 17,560,596
Open 18.56
Bid (Size) 17.75 (9)
Ask (Size) 17.76 (41)
Prev. Close 18.54
Today's Range 17.62 - 18.58
52wk Range 11.48 - 22.80
Shares Outstanding 1,110,352,397
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What Analysts Are Saying About Teva Pharmaceutical Indus Stock
Via Benzinga
Why Teva Pharmaceutical Stock Is Sinking Today
Via The Motley Fool

Performance

YTD
-16.64%
-16.64%
1 Month
-20.45%
-20.45%
3 Month
-4.49%
-4.49%
6 Month
+1.86%
+1.86%
1 Year
+51.36%
+51.36%

More News

Read More
Teva Pharmaceutical Industries (TEVA) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Crude Oil Down 1.5%; Teva Pharmaceutical Shares Plummet
Via Benzinga
Exposures Fossil Fuels
Stocks Scatter As Investors Prepare For Fed Remarks
Via Talk Markets
Topics Economy Stocks / Equities
Exposures Interest Rates
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today
Via Benzinga
Peering Into Teva Pharmaceutical Indus's Recent Short Interest
Via Benzinga
Stocks Tick Down Ahead Of Fed Meeting, Nvidia Jitters Resume, Trump Media Rallies: What's Driving Markets Wednesday?
Via Benzinga
Topics Economy Government
Exposures Interest Rates Political
Nasdaq Down Over 100 Points; Corning Posts Upbeat Earnings
Via Benzinga
Teva Pharmaceutical Posts Lower Revenue. Stock Slips.
Via Investor's Business Daily
Teva Pharmaceutical Stock Falls On Q4 Earnings: What's Going On?
Via Benzinga
Manhattan Associates, LendingClub And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Teva's Duvakitug Set To Shake Up IBD Treatment, Analyst Highlights Competitive Data
Via Benzinga
Earnings Scheduled For January 29, 2025
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
From Alvotech
Via GlobeNewswire
FDA Warns Of Severe Allergic Reaction Risk With Teva's Multiple Sclerosis Drug
Via Benzinga
Exposures Product Safety
Promising Signs: TEVA PHARMACEUTICAL-SP ADR Setting the Stage for a Breakout.
Via Chartmill
Teva Challenges Drug Price Law's Impact On Innovation, Generics
Via Benzinga
Topics Economy
Exposures Interest Rates
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
Via Benzinga
Topics Economy
Exposures Interest Rates
Nvidia To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States
From Teva Pharmaceutical Industries Ltd; Samsung Bioepis Co., Ltd.
Via GlobeNewswire
Catalyst Pharmaceuticals Settles Patent Litigation Case With Teva Pharmaceutical
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.